What is Aarey Drugs & Pharmaceuticals Net Margin %?
Aarey Drugs & PharmaceuticalsBOM:524412 -2.00%60 Net Margin % is 0.82% as of Mar. 2026, which is 40% below its 10-year median of 1.36. GuruFocus rates BOM:524412 with a GF Score™ of 60/100 and a GF Value™ of ₹58.28 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 954 Drug Manufacturers companies, Aarey Drugs & Pharmaceuticals ranks worse than 64.36% on this metric.
The historical rank and industry rank for Aarey Drugs & Pharmaceuticals's Net Margin % or its related term are showing as below:
BOM:524412'
s Net Margin % Range Over the Past 10 Years
Min: 0.84 Med: 1.36 Max: 1.93
Current: 0.96
BOM:524412's Net Margin % is ranked worse than 64.36% of 954
companies
in the Drug Manufacturers industry
Industry Median: 5.695
vs BOM:524412: 0.96
Aarey Drugs & Pharmaceuticals (BOM:524412) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Aarey Drugs & Pharmaceuticals Net Margin % Related Terms
Aarey Drugs & Pharmaceuticals Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aarey Drugs & Pharmaceuticals Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where Aarey Drugs & Pharmaceuticals's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aarey Drugs & Pharmaceuticals (BOM:524412) has a Net Margin % of 0.82% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Aarey Drugs & Pharmaceuticals and its competitors. This is 40% below median its historical median of 1.36. Over the past decade, Aarey Drugs & Pharmaceuticals' Net Margin % has ranged from 0.84 to 1.93. According to the industry distribution chart, Aarey Drugs & Pharmaceuticals ranks #614 out of 954 companies in the Drug Manufacturers industry, placing it in the top 64.4%.
Is Aarey Drugs & Pharmaceuticals' Net Margin % too high?
Aarey Drugs & Pharmaceuticals' current Net Margin % of 0.82% is 40% below median its 10-year median of 1.36. Over the past 10 years, this metric has ranged from a low of 0.84 to a high of 1.93. The Drug Manufacturers industry median Net Margin % is 5.70. Aarey Drugs & Pharmaceuticals' value of 0.82% is 85.6% below this industry median. Based on the distribution chart, Aarey Drugs & Pharmaceuticals ranks #614 out of 954 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aarey Drugs & Pharmaceuticals has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aarey Drugs & Pharmaceuticals' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aarey Drugs & Pharmaceuticals ranks #614 out of 954 companies for Net Margin %. This places Aarey Drugs & Pharmaceuticals in the lower half of its industry. The industry median Net Margin % is 5.70. Aarey Drugs & Pharmaceuticals' value of 0.82% is 85.6% below this benchmark. Historically, Aarey Drugs & Pharmaceuticals' own Net Margin % has ranged from 0.84 to 1.93 over the past decade. While the company's 10-year median is 1.36 vs. the industry median of 5.70, Aarey Drugs & Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.70, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aarey Drugs & Pharmaceuticals's current Net Margin % of 0.82% is 85.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Aarey Drugs & Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aarey Drugs & Pharmaceuticals's current Net Margin % is 0.82%, which is 40% below median its own 10-year median of 1.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarey Drugs & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Aarey Drugs & Pharmaceuticals (BOM:524412) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹58.28, compared to a current price of ₹89.67 — trading 53.9% above its estimated fair value. The current Net Margin % is 0.82%, which is 40% below median its 10-year median of 1.36 and 85.6% below the Drug Manufacturers industry median of 5.70. Aarey Drugs & Pharmaceuticals' overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Aarey Drugs & Pharmaceuticals (BOM:524412), the current Net Margin % is 0.82% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aarey Drugs & Pharmaceuticals (BOM:524412) Overvalued in 2026?
Based on GuruFocus' analysis, Aarey Drugs & Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹89.67 is trading 53.9% above its estimated GF Value™ of ₹58.28.
GuruFocus considers Aarey Drugs & Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for BOM:524412:
Net Margin %: 0.82% (40% below median its 10-year median of 1.36)
GF Value™: ₹58.28 vs. price of ₹89.67 (53.9% above fair value)
Industry Position: 85.6% below the Drug Manufacturers median (#614 of 954)
No single metric tells the full story. See the BOM:524412 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aarey Drugs & Pharmaceuticals Business Description
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, and BMD among others. The company principally carries out its business operations in India.
60GF Score
Get the complete analysis for BOM:524412
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524412 has been successfully added to your 
